Controlling high BP in Indians: ICMR, WHO, MoHFW together to expand India Hypertension Control Initiative in 100 districts
Advertisement
IHCI will expand to 100 districts across India covering all the states. The project will accelerate the implementation of quality hypertension treatment for over 15 crore population over the next four years and prevent deaths from heart attack, stroke and kidney failure.
New Delhi: Indian Council of Medical Research (ICMR), in collaboration with World Health Organization and Ministry of Health and Family Welfare, has recently announced nationwide expansion of their program India Hypertension Control Initiative (IHCI).
Launched in November 2017 IHCI has enrolled more than three lakh patients with high blood pressure in the government health facilities in 25 selected districts of the country in the states of Punjab, Madhya Pradesh, Kerala, Telangana, and Maharashtra.
Now IHCI will expand to 100 districts across India covering all the states. The project will accelerate the implementation of quality hypertension treatment for over 15 crore population over the next four years and prevent deaths from heart attack, stroke and kidney failure.
New Delhi: Indian Council of Medical Research (ICMR), in collaboration with World Health Organization and Ministry of Health and Family Welfare, has recently announced nationwide expansion of their program India Hypertension Control Initiative (IHCI).
Launched in November 2017 IHCI has enrolled more than three lakh patients with high blood pressure in the government health facilities in 25 selected districts of the country in the states of Punjab, Madhya Pradesh, Kerala, Telangana, and Maharashtra.
Now IHCI will expand to 100 districts across India covering all the states. The project will accelerate the implementation of quality hypertension treatment for over 15 crore population over the next four years and prevent deaths from heart attack, stroke and kidney failure.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.